drugset / Trial / NCT02733952

Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy

NCT02733952

Phase 3 Unknown 70 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy

Timeline

Start
2015-08
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.